Breaking News
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
November 17, 2017 - Just-in-time 3-D implants set to transform tumor surgery
November 17, 2017 - Skin patch offers hope for people with peanut allergy
November 17, 2017 - Scientists identify biomarkers that predict risk of death in Ebola patients
November 17, 2017 - Heart attack, stroke patients have improved outcomes when statins are prescribed after discharge
November 17, 2017 - Majority of people do not understand link between obesity and cancer, study shows
November 17, 2017 - Deep vein thrombosis accurately diagnosed by GPs trained in compression ultrasonography
November 17, 2017 - New Kevlar-based hydrogel recreates the magic of natural cartilage
November 17, 2017 - FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence
November 17, 2017 - Foods made with biofortified corn flour and eggs retain vitamin A after cooking
November 17, 2017 - Integrated Care Winning the Day for Healthcare Companies
November 17, 2017 - CPAP may be superior to gastric banding for severe sleep apnea
November 17, 2017 - New pain relievers reduce opiate overdose risk
November 17, 2017 - Brain astrocytes could play key role in pathogenesis of Alzheimer’s disease
November 17, 2017 - Researchers test whether LVAD surgery could reverse frailty in older adults with heart failure
November 17, 2017 - ATS debuts new video to highlight dangers of flavored tobacco
November 17, 2017 - Medicaid expansion under ACA more likely to increase smoking cessation rates among low-income adults
November 17, 2017 - FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII
November 17, 2017 - 1 in 5 Americans Still Uses Tobacco, Gov’t. Reports: MedlinePlus Health News
November 17, 2017 - People with psychotic-like experiences spend less time in healthy brain states
November 17, 2017 - Hospital Readmission Reduction Program linked to increase in death rates, study finds
November 17, 2017 - Study finds rising rates of marijuana use in states where it is legal
November 17, 2017 - Scientists unveil pathology underlying optic nerve hypoplasia in children
November 17, 2017 - Novel device designed to treat diastolic heart failure found safe and effective
November 17, 2017 - Smoking parents may underestimate kid’s exposure to secondhand smoke
November 17, 2017 - FAIMS technology holds potential to be effective screening tool for pancreatic cancer
November 17, 2017 - Applying AFM to study the viscoelastic properties of cells
November 17, 2017 - FDA Alert: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall
November 17, 2017 - High cognitive ability not a safeguard from conspiracies, paranormal beliefs
November 17, 2017 - Computerized speed of processing training results in decreased risk of dementia
November 17, 2017 - Sexual activity poses exceedingly small risk in causing sudden cardiac arrest
Web-Based Personalized Intervention May Reduce RA Risk

Web-Based Personalized Intervention May Reduce RA Risk

image_pdfDownload PDFimage_print

Action Points

  • A personalized medicine approach that translates epidemiologic findings about genetics, biomarkers, and behavior into a personal, web-based intervention may help people reduce their risk of rheumatoid arthritis (RA).
  • Note that individuals with the highest lifetime RA risk were most motivated to improve behavior, despite learning about non-modifiable factors like age, sex, genetics, and autoantibodies.

A personalized medicine approach that translates epidemiologic findings about genetics, biomarkers, and behavior into a personal, web-based intervention appeared to help people reduce their risk of rheumatoid arthritis (RA), according to new research from Brigham and Women’s Hospital and Harvard Medical School in Boston.

First-degree relatives of RA patients who received personalized disclosure and education about RA were 23% more likely to increase their motivation to improve risk-related behaviors over 6 months compared with those who received standard, non-personalized education (RR 1.23, 95% CI 1.01-1.51, P=0.043), reported Jeffrey Sparks, MD, MMSc, and colleagues, writing online in Arthritis Care and Research.

Compared with those who received standard RA education, relatives who received personalized information reported increasing their fish intake (45% versus 22.1%, P=0.005), brushing their teeth more frequently (40.7% versus 22.9%, P=0.01), flossing more frequently (55.7% versus 34.8%, P=0.004), and quitting smoking (62.5% versus 0.0% among 11 smokers, P=0.18). Individuals with the highest lifetime RA risk were most motivated to improve behavior, despite learning about non-modifiable factors like age, sex, genetics, and autoantibodies.

“Genetic risk disclosure alone has had limited impact on other health behavior changes,” the team wrote. “Our study is one of the few to evaluate the effect of factors beyond genetics by including the impact of biomarkers, demographics, and behavioral risk factors to motivate positive health behaviors changes.”

Having a first-degree relative with RA increases personal RA risk by four times, and while both genetic and behavioral RA risk factors are shared within families, choice plays an important role. “The population attributable risk for RA of known behavioral factors is about 40%, suggesting that improving these health behaviors may reduce risk of developing RA. Intention to change behavior is the first step toward persistent behavior change, which may subsequently lead to demonstrable effects on health outcomes such as autoantibody development or RA risk.”

In this proof-of-concept trial, the researchers recruited unaffected parents, children, and siblings of RA patients at Brigham and Women’s Hospital from 2013 to 2016. Excluded were relatives who were older than age 70 or who had symptoms or a diagnosis of any systemic rheumatic disease.

The investigators incorporated a Personalized Risk Estimator for RA (PRE-RA) into the study, a web-based tool they had previously designed to disclose personalized RA risk based on genetics, biomarkers, demographics, and risk-related behavior. Four behavioral factors were included in the RA risk estimate: cigarette smoking, excess body weight, poor oral health, and low fish intake. The tool showed participants their genetic (HLA-DRB1) and autoantibody (rheumatoid factor and cyclic citrullinated peptide) results, presented relative and absolute lifetime risk of RA, and provided personalized education to modify behavior.

Participants were randomized to one of three groups:

  • The comparison arm (n=80) received non-personalized, standard education about RA epidemiology, symptoms, and diagnosis
  • The PRE-RA arm (n=78) received the web-based PRE-RA risk disclosure and education tool
  • The PRE-RA Plus arm (n=80) received the PRE-RA tool plus a 45-minute session with a health educator who helped interpret findings and taught participants about changing risk-related behavior

Most participants were female (76.5%), white (87.0%), and had greater than high school education (87.8%). Mean age was 43.4 in the comparison group and 46.7 in the PRE-RA groups.

The primary outcome was readiness for change in four areas associated with RA risk — smoking, diet, exercise, and dental hygiene — using the transtheoretical model (TTM) of behavior change. TTM, a tool developed by James Prochaska, PhD, director of the Cancer Prevention Resource Center at the University of Rhode Island, assesses how ready an individual is to make healthier choices. The tool includes a contemplation ladder with rungs corresponding to stages of motivation progressing through pre-contemplation, contemplation, preparation, action, and maintenance, and was validated originally in studies of behavioral changes in smokers.

Sparks and colleagues defined increased motivation to improve as an increase in any ladder score compared with baseline. The team also evaluated self-reported changes in RA risk-related behaviors as secondary outcomes.

For the primary analysis, the researchers combined the two PRE-RA arms into a single group (n=158). Over three time points — immediately, 6 weeks, and 6 months after intervention — those in the PRE-RA group were more likely to increase motivation to improve behavior than those in the comparison arm (age-adjusted RR 1.23, 95% CI 1.01-1.51, P=0.043).

Individuals in the PRE-RA group were also more likely to have ≥1 point increase in the dental hygiene ladder than those in the comparison group (26.3% versus 14.1%; age adjusted difference of 12.6%, 95% CI 2.6-22.5%, P=0.014). The proportion of participants who had an increase in diet and exercise ladders was similar between the PRE-RA group and the comparison arm.

At 6 months post-intervention, more individuals in the PRE-RA group reported brushing and flossing teeth more frequently, increasing fish intake, and stopping smoking than those in the comparison group. At all time points, the web-based PRE-RA tool performed similarly well with or without a health educator.

These results provide a rationale for larger studies evaluating the effect of behavior changes on clinical outcomes like autoantibody production or RA development, the researchers said

Regarding study limitations, Sparks and colleagues said that due to the trial’s nature, it was not possible to blind the participants to their educational intervention. In addition, since most of the participants were well-educated women, the results might not be generalizable to other populations. Furthermore, the outcomes were self-reported, so participants actually might not have improved behaviors.

This research was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

No conflicts of interest were noted

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-10-23T15:30:00-0400

Tagged with:

About author

Related Articles